ECM
IMGN

ETrade Capital Management’s Immunogen Inc IMGN Stock Holding History

ETrade Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,212
Closed -$57K – 881
2019
Q4 		$57K Sell
11,212
-1,843
-14% -$6.25K ﹤0.01% 782
2019
Q3 		$32K Buy
13,055
+909
+7% +$2.41K ﹤0.01% 785
2019
Q2 		$26K Buy
+12,146
New +$28.7K ﹤0.01% 783
2018
Q1 		– Sell
-11,433
Closed -$73K – 780
2017
Q4 		$73K Sell
11,433
-87
-0.8% -$537 ﹤0.01% 730
2017
Q3 		$88K Sell
11,520
-2,075
-15% -$13.8K ﹤0.01% 690
2017
Q2 		$97K Buy
13,595
+1,653
+14% +$7.56K ﹤0.01% 688
2017
Q1 		$46K Buy
+11,942
New +$34.9K ﹤0.01% 638

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ETrade Capital Management's IMGN Position: Q1 2020 in Review

ETrade Capital Management sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 11,212 shares — an estimated $57K sold.

ETrade Capital Management first reported a position in IMGN in Q1 2017 and held it in 7 quarters. The position peaked at $97K in Q2 2017. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • ETrade Capital Management reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • ETrade Capital Management sold 11,212 Immunogen Inc shares in Q1 2020, an estimated $57K.
  • ETrade Capital Management first reported a position in Immunogen Inc in Q1 2017 and held it in 7 quarters.
  • ETrade Capital Management's Immunogen Inc position peaked at $97K in Q2 2017.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on ETrade Capital Management's 13F filing for Q1 2020, filed 8 May 2020.